Maharashtra FDA Labels Vimal Elaichi Ads as Surrogate Advertising

The Maharashtra Food and Drug Administration (FDA) has issued a notice stating that promotional material for Vimal Elaichi, a popular spice brand, appears to be surrogate advertising. Surrogate advertising refers to the indirect promotion of a product through another brand or product, often used to circumvent advertising restrictions. The FDA’s observation suggests that the Vimal Elaichi ads may be leveraging another product or brand to promote the spice, potentially violating the state’s advertising guidelines. The agency has requested the company to withdraw the ads and warned that non‑compliance could lead to penalties.